Screener
Cytokinetics CYTK Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Cytokinetics’s reported figures.
The source filing: Cytokinetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338217
FAQ
- What is Cytokinetics's free cash flow?
- Cytokinetics (CYTK) reported free cash flow of -$164.17M in Q2 2026.
- How has Cytokinetics's free cash flow changed year-over-year?
- Cytokinetics's free cash flow decreased by 24.0% year-over-year, from -$132.38M to -$164.17M.
- What is the long-term trend for Cytokinetics's free cash flow?
- Over 4 years (2021 to 2025), Cytokinetics's free cash flow has grown at a 29.3% compound annual growth rate (CAGR), from -$191.39M to -$534.82M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Cytokinetics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude